Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with...

Industry: Biotechnology

Sector: Healthcare

Phone: 604-921-1810

Fax: 604-921-1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

UnicornPicks Aug. 25 at 6:35 PM

We shared these ideas $SUGP $CGTX $BCTX and $OPAD that hit +69% ROI on the intraday trade idea! Let's goooo

0 · Reply

SmallCapGrowth Aug. 25 at 6:30 PM

$BCTX awarded $2.05M non-dilutive - The Hunt for the Next 10 Bagger https://investorshangout.com/post/view?id=6784568

0 · Reply

JudithJohnson203 Aug. 25 at 6:19 PM

$BCTX Low float biotech, confirmation above key level or pass

0 · Reply

rp6577 Aug. 25 at 5:41 PM

$BCTX 🔥

0 · Reply

letsdodiz Aug. 25 at 5:25 PM

$BCTX The management has negative credibility at this point. They will start issuing shares to employees now that they reduced the old investor shares to less than 1%.

0 · Reply

dlev18 Aug. 25 at 5:12 PM

$BCTX lol my avg is over $100 now gg

1 · Reply

topstockalerts Aug. 25 at 5:09 PM

$BCTX making a move.. keep an eye

0 · Reply

SmallCapGrowth Aug. 25 at 4:58 PM

Whale Team : CANCER STOCK ALERT: $BCTX announced that... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176617043 via @

0 · Reply

topstockalerts Aug. 25 at 4:36 PM

$BCTX crazy volatility ......

0 · Reply

2maligators Aug. 25 at 4:34 PM

$BCTX $30 more to go and I’m gravy!

1 · Reply

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 4 days ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 12 days ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 25 days ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 26 days ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 27 days ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 4 weeks ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 5 weeks ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 5 weeks ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 5 weeks ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 6 weeks ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 6 weeks ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 6 weeks ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 6 weeks ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 7 weeks ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jun 24, 2025, 7:30 AM EDT - 2 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 4, 2025, 7:30 AM EDT - 2 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Jun 2, 2025, 7:30 AM EDT - 3 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

May 27, 2025, 7:30 AM EDT - 3 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

May 23, 2025, 7:30 AM EDT - 3 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

May 20, 2025, 7:30 AM EDT - 3 months ago

BriaCell CEO Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 4 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

Apr 28, 2025, 4:05 PM EDT - 4 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Apr 28, 2025, 7:30 AM EDT - 4 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Apr 24, 2025, 8:00 PM EDT - 4 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Apr 24, 2025, 10:11 AM EDT - 4 months ago

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

Apr 24, 2025, 7:30 AM EDT - 4 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Apr 23, 2025, 7:30 AM EDT - 4 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 22, 2025, 7:30 AM EDT - 4 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

Apr 16, 2025, 7:30 AM EDT - 4 months ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

Mar 26, 2025, 8:00 AM EDT - 5 months ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

Mar 20, 2025, 8:00 AM EDT - 5 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer

Feb 5, 2025, 6:15 PM EST - 7 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Feb 5, 2025, 4:05 PM EST - 7 months ago

BriaCell Therapeutics Announces Closing of Public Offering

Feb 3, 2025, 7:59 PM EST - 7 months ago

BriaCell Therapeutics Announces Pricing of Public Offering

Feb 3, 2025, 4:45 PM EST - 7 months ago

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

Feb 3, 2025, 7:30 AM EST - 7 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

Jan 27, 2025, 6:42 PM EST - 7 months ago

BriaCell Announces Completion of 15:1 Share Consolidation

Jan 3, 2025, 5:05 PM EST - 8 months ago

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

Dec 17, 2024, 4:05 PM EST - 8 months ago

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

Dec 17, 2024, 4:05 PM EST - 8 months ago

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

Dec 13, 2024, 4:05 PM EST - 9 months ago

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

Dec 13, 2024, 7:50 AM EST - 9 months ago

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

Dec 11, 2024, 11:54 PM EST - 9 months ago

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

Dec 11, 2024, 4:05 PM EST - 9 months ago

BriaCell Therapeutics Announces Proposed Public Offering

Dec 11, 2024, 7:50 AM EST - 9 months ago

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

Dec 2, 2024, 7:50 AM EST - 9 months ago

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

Nov 26, 2024, 7:50 AM EST - 9 months ago

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

Nov 25, 2024, 7:50 AM EST - 9 months ago

BriaCell Provides Update to its Board of Directors

Nov 21, 2024, 7:50 AM EST - 9 months ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

UnicornPicks Aug. 25 at 6:35 PM

We shared these ideas $SUGP $CGTX $BCTX and $OPAD that hit +69% ROI on the intraday trade idea! Let's goooo

0 · Reply

SmallCapGrowth Aug. 25 at 6:30 PM

$BCTX awarded $2.05M non-dilutive - The Hunt for the Next 10 Bagger https://investorshangout.com/post/view?id=6784568

0 · Reply

JudithJohnson203 Aug. 25 at 6:19 PM

$BCTX Low float biotech, confirmation above key level or pass

0 · Reply

rp6577 Aug. 25 at 5:41 PM

$BCTX 🔥

0 · Reply

letsdodiz Aug. 25 at 5:25 PM

$BCTX The management has negative credibility at this point. They will start issuing shares to employees now that they reduced the old investor shares to less than 1%.

0 · Reply

dlev18 Aug. 25 at 5:12 PM

$BCTX lol my avg is over $100 now gg

1 · Reply

topstockalerts Aug. 25 at 5:09 PM

$BCTX making a move.. keep an eye

0 · Reply

SmallCapGrowth Aug. 25 at 4:58 PM

Whale Team : CANCER STOCK ALERT: $BCTX announced that... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176617043 via @

0 · Reply

topstockalerts Aug. 25 at 4:36 PM

$BCTX crazy volatility ......

0 · Reply

2maligators Aug. 25 at 4:34 PM

$BCTX $30 more to go and I’m gravy!

1 · Reply

ArgusDune1971 Aug. 25 at 4:32 PM

$BCTX Offering in September 2024 Offering in December 2024 Reverse split in January 2025 Offering in February 2025 Offering in July 2025 Reverse split in August 2025 AND, COMING SOON Offering in September 2025 Offering in December 2025 Reverse split in January 2026

0 · Reply

Concretejim Aug. 25 at 4:26 PM

$BCTX I love to see the optimism youre not drowning youre getting a drink of water lol

0 · Reply

makedatbread88 Aug. 25 at 4:26 PM

$BCTX 1.76M float recent reverse split today keep an eye on it getting bought up today on first day of its reverse split someone wants in badly

0 · Reply

SmallCapGrowth Aug. 25 at 4:20 PM

$BCTX BriaCell announced that @theNCI, has awarded the Company a research grant of $2,054,651 to advance Bria-PROS+, BriaCell’s next generation personalized off-the-shelf #immunotherapy for #prostatecancer. Find details: https://bit.ly/47e4zQy $BCTX $BCTXW #STOCKSTOBUY

0 · Reply

ArgusDune1971 Aug. 25 at 4:20 PM

$BCTX Briacell will use the PR to issue shares. It's what they do. Everytime.

1 · Reply

SmallCapGrowth Aug. 25 at 4:10 PM

BriaCell announced that @theNCI, has awarded the Company a research grant of $2,054,651 to advance Bria-PROS+, BriaCell’s next generation personalized off-the-shelf #immunotherapy for #prostatecancer. Find details: https://bit.ly/47e4zQy $BCTX $BCTXW

0 · Reply

topstockalerts Aug. 25 at 4:01 PM

$BCTX comeback.. 🚀

0 · Reply

JediGreen Aug. 25 at 3:58 PM

$BCTX This could just be getting started. Around 1.8 million shares I think.

1 · Reply

QES Aug. 25 at 3:57 PM

$BCTX I hope @ArgusDune1971 went long today.

1 · Reply

rp6577 Aug. 25 at 3:56 PM

$BCTX chase the bears out the door

0 · Reply

JediGreen Aug. 25 at 3:52 PM

$BCTX like I said bullish baby.

0 · Reply

QES Aug. 25 at 3:52 PM

$BCTX The NCI news was just over-the-top! The stock should have a clean run for several months!

1 · Reply

Market Cap	4.73M
Revenue (ttm)	0.00
Net Income (ttm)	-4.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	298,534
Avg Vol	1,374,836
Day's Range	N/A - N/A
Shares Out	6.78M
Stochastic %K	42%
Beta	1.07
Analysts	Sell
Price Target	$32.00